Tackling the Opioid Epidemic

Meeting Patients Where They Are: Lessons from the UK First Bridge Clinic

Activity Details
  • Credit Amounts:
    • CME: 0.75
    • CPE: 0.75
    • Other: 0.75
    • CDE: 0.75
    • CPHCE: 0.75
    • CNE: 0.75
  • Cost: Free
  • Release: Jul 1, 2022
  • Expires: Jun 30, 2025
  • Estimated Time to Complete:
    45 Minutes
  • Average User Rating:
    (12 Ratings)


Devin A.  Oller Devin A. Oller, MD, FACO, FASAM
Associate Program Director
University of Kentucky
Internal Medicine Residency Program
NIH-funded HEALing Communities Study
Lexington, Kentucky

Needs Statement

Low-threshold medication for opioid use disorder (MOUD) clinics represent a key link between episodes of illness driven by opioid use disorder (OUD) and effective management of OUD.

Sharing lessons learned from the roll-out of low-threshold MOUD clinics is needed to improve patient care.

Target Audience

Health care professionals/prescribers including physicians, physician assistants, nurses, advance practice registered nurses, pharmacists, dentists, dental hygienists, social workers, counselors, and any others interested in the prevention of and treatment for substance abuse disorder and sustained recovery.


Upon completion of this educational activity, participants will be able to:

  • Identify critical challenges facing patients seeking treatment for Opioid Use Disorder (OUD)
  • Describe the features and team structure of a low-threshold OUD clinic
  • Discuss early outcomes data from the UK First Bridge Clinic roll-out


In support of improving patient care, this activity has been planned and implemented by UK HealthCare CECentral and Kentucky Office of Drug Control Policy. University of Kentucky HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This enduring material is designated for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

This training has been approved by the KBML as meeting the statutory requirements of HB1. 0619-H5.25-CECOW1

This knowledge-based activity will award 0.75 contact hours (0.075 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers.

UK Healthcare CECentral certifies this activity for 0.75 hours of participation.

This online course meets regulatory requirements for 0.75 hours credit as permitted by 201 KAR 8:532 for dentists and 201 KAR 8:562 for dental hygienists.

University of Kentucky College of Public Health certifies that this educational activity was designated for 0.75 hours of Public Health Continuing Education (CPHCE) credit. This course is approved for continuing education by the University of Kentucky College of Public Health. ()

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 nursing contact hours.

Faculty Disclosure

No speaker or planners have any relevant financial relationships to disclose. 

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.


This activity is jointly provided by the University of Kentucky and Kentucky Office of Drug Control Policy.

In collaboration with Kentucky Injury Prevention and Research Center (KIPRC).